Clinical Trial Update: Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing continuing versus stopping a P2Y12 inhibitor in patients on dual antiplatelet therapy undergoing dental procedures. The trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Diseases

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Chiang Mai University | Conditions: Dental Diseases, Antiplatelet Agents | Phase 4 | Status: UNKNOWN